← All companies
Summit Therapeutics Inc.
SMMT - CIK 0001599298
Market cap$10.33 B
Rank#923
SEC filings532
The table below shows Summit Therapeutics Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $106.52M | $238.55M | $297.87M | $211.53M | $93.78M | $28.43M |
| Short-term investments | $492.22M | $0.00 | $0.00 | $149.79M | $393.12M | $297.04M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.